Page last updated: 2024-09-04

mdl 100173 and bradykinin

mdl 100173 has been researched along with bradykinin in 1 studies

Compound Research Comparison

Studies
(mdl 100173)
Trials
(mdl 100173)
Recent Studies (post-2010)
(mdl 100173)
Studies
(bradykinin)
Trials
(bradykinin)
Recent Studies (post-2010) (bradykinin)
72014,1953551,520

Protein Interaction Comparison

ProteinTaxonomymdl 100173 (IC50)bradykinin (IC50)
B2 bradykinin receptorHomo sapiens (human)0.0018

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, B; Beach, DC; Dage, RC; Flynn, GA; French, JF; Giroux, EL; Koehl, JR; Mehdi, S1

Other Studies

1 other study(ies) available for mdl 100173 and bradykinin

ArticleYear
Characterization of a dual inhibitor of angiotensin I-converting enzyme and neutral endopeptidase.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 268, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Benzazepines; Bradykinin; Male; Molecular Structure; Neprilysin; Peptidyl-Dipeptidase A; Prodrugs; Pyridines; Rats; Rats, Sprague-Dawley

1994